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Antibacterial peptideHere, we investigated antibacterial effects of Rev–NIS and suggested the role of positively charged amino acids
on membrane pore forming activity of the peptide in bacterial cells, by synthesizing two analogs, Anal R and
Anal S. Based on the amphipathic property of Rev–NIS, Anal R and Anal S were designed by substituting E1 and
L3 to R and L3 to S, respectively. The circular dichroism (CD) spectroscopy showed that Anal R and Anal S have
the same conformation of Rev–NIS, with a signiﬁcant fraction of helical structure. In succession, the
antibacterial susceptibility testing showed that Rev–NIS and its analogs possessed signiﬁcant activities (Anal
RNRev–NISNAnal S), without hemolytic effects, against bacterial pathogens including antibiotics-resistant
strains. Moreover, the membrane studies, 3,3′-dipropylthiadicarbocyanine iodide (diSC35) staining and FITC-
dextran (FD) leakage assay demonstrated that the analogs as well as Rev–NIS acted on the bacterial
membranes and potently made pores, with the hydrodynamic radius between 1.4 nm and 2.3 nm. Especially,
Anal R made larger pores than other peptides, with the radius between 2.3 nm and 3.3 nm. These results also
corresponded to the result of antibacterial susceptibility testing. In summary, this study indicates that the two
arginine residues aremore inﬂuential than the hydrophobicity or the helicity, regarding themolecular activity
of the peptide, and ﬁnally suggests that Anal R peptide may be applied to novel antibacterial agents.3′-dipropylthiadicarbocyanine
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Recently, due to the emergence of organisms possessing resistance
to several antibiotics [1,2], a variety of diseases are becoming
increasingly difﬁcult to treat, including microorganisms responsible
for infections in hospitalized patients, food-borne pathogens, and
sexually transmitted pathogens, some of which are known to be
resistant to most antimicrobial drugs [3–5]. The clinical impact of the
above noted resistance is regarded as immense, characterized by
increased cost, morbidity, or mortality [6,7]. Therefore, the increasing
resistance against various commonly used antibiotic agents requires
immediate actions, continuous studies and the eventual suggestion of
novel bactericidal and fungicidal agents [8,9]. Although the search for
novel naturally occurring antimicrobial molecules such as antimicro-
bial peptides (AMPs) has focused on the molecules isolated from
plants or animals [10], actually, there is no limitation with respect tothe sources for the selection of AMPs. Most AMPs can interact,
permeate and physically disrupt the cell plasma membrane, causing
damages that are hard to repair and sometimes fatal, in contrast to
conventionally used antibiotics that are targeting speciﬁc intracellular
enzymes or DNA. Conclusively, resistance may occur with lower
probability [11].
HIV-1 encodes the regulatory protein Rev constantly shuttling
between the nucleus and the cytoplasm in the host cells. This protein
is concerned in the control of a signal-mediated active import and
export system of HIV-1, and the function of NIS region is especially
critical [12–15]. If the NIS does not carry out its role, Rev may migrate
back through the nuclear pore against the well-controlled nucleocy-
toplasmic shuttling to conduct its own role in each compartment. In
the whole sequence of NIS, residues 11–20 (Rev–NIS, ELLKAVRLIK)
are composed of the conserved hydrophilic motif forming an
amphipathic helix. This helical motif was regarded to be critical
with respect to the function of NIS and Rev itself [16]. Previously, we
found that Rev–NIS exerted antifungal activities by disrupting fungal
membranes of Candida albicans and this result suggested a therapeu-
tic potential as new antifungal agents [17]. In this study, ﬁrst, we
investigated the antibacterial activity of Rev–NIS. Thereafter, we
designed and synthesized two analogs, Anal R and Anal S, to
investigate the effect of positively charged amino acids regarding
the antibacterial activity of the peptides. Concretely, Anal R and Anal S
were designed by substituting the speciﬁc amino acids, Glu1 and Leu3
to Arg (Anal R) and Leu3 to Ser (Anal S), respectively.
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2.1. Solid-phase peptide synthesis
Anygen Co. (Gwangju, Korea) carried out the peptide synthesis.
Anygen Co. offers the following procedures for peptide synthesis. The
assembly of peptides consisted of a 60-min cycle for each residue at
ambient temperature as follows: (1) the 2-chlorotrityl (or 4-
methylbenzhydrylamine amide) resin was charged to a reactor and
thenwashedwith DCM and DMF, respectively, and (2) a coupling step
with vigorous shaking using a 0.14 mM solution of Fmoc-L-amino
acids and Fmoc-L-amino acids preactivated for approximately 60 min
with a 0.1 mM solution of 0.5 M HOBt/DIC in DMF. Finally, the peptide
was cleaved from the resin using a TFA cocktail solution at ambient
temperature [18,19].
2.2. Peptide characterization
Analytical and preparative reverse-phase HPLC runs were per-
formed with a Shimadzu 20 A or 6 A gradient system. Data was
collected using an SPD-20 A detector at 230 nm. Chromatographic
separations were achieved with a 1%/min linear gradient of buffer B in
A (A=0.1% TFA in H2O; B=0.1% TFA in acetonitrile (CH3CN)) over
40 min at ﬂow rates of 1 and 8 ml/min using Shimadzu C18 analytical
(5 μm, 0.46 cm×25 cm) and preparative C18 (10 μm, 2.5 cm×25 cm)
columns, respectively. The HPLC retention time (min) of Rev–NIS,
Anal R, and Anal S is 18.992, 13.550, and 15.433, respectively. The
mass spectrometry was also performed. The observed mass of Rev–
NIS, Anal R, and Anal S is 1183.2, 1251.9, and 1155.8, respectively.
2.3. CD analysis
CD spectra of the peptides were recorded using a spectro-
polarimeter (Jasco J720; Japan). All samples were maintained at
25 °C during the analysis. Four scans per sample were performed over
a wavelength range of 190–250 nm at 0.1 nm intervals. The spectra
were measured in 50% (v/v) TFE and 30 mM SDS in 10 mM sodium
phosphate buffer, pH 7.2, respectively, at 25 °C using a 1-mm path-
length cell. The peptide concentrations were 50 μM. Themean residue
ellipticity, [θ], is given in deg∙cm2∙dmol−1: [θ]=[θ]obs (MRW/10lc),
where [θ]obs is the ellipticity measured in millidegrees, MRW is the
mean residue molecular weight of the peptide, c is the concentration
of the sample in mg/ml, and l is the optical path-length of the cell in
cm [20,21].
2.4. Isolation of bacterial strains and determining of antibacterial
susceptibility
All bacterial strains were isolated from a tertiary teaching hospital
in Daegu, South Korea. All isolates were processed by the MicroScan
WalkAway 96 system for genus and species identiﬁcation and the
determination of the antimicrobial susceptibility testing. MicroScan
Gram positive MIC/combo (PC1A) panel, Gram negative MIC/combo
(NC44) panel, and Gram negative breakpoint combo (NBC39) panel
were used in determining antimicrobial agent susceptibility and
identiﬁcation to the species level of Enterococcus faecium, Staphylo-
coccus aureus, Escherichia coli, and Pseudomonas aeruginosa,
respectively.
Inoculum suspensions for the system were processed on the same
day using the same fresh 18- to 24-h subculture plate. The Prompt
Inoculation System-D was used to standardize inocula for microdilu-
tion antimicrobial susceptibility tests. All procedures were performed
according to the manufacturers' recommendations. All antimicrobial
susceptibility tests were performed in compliance with current CLSI
methods as recommended by themanufacturers' package inserts with
the products. Quality control was monitored by using the followingorganisms: S. aureus ATCC 29213, P. aeruginosa ATCC 27853, and E. coli
ATCC 25922.
2.5. Antibacterial susceptibility testing
Bacterial cells (2×107/ml) were inoculated into a Mueller-
Hinton broth and 0.1 ml/well was dispensed onto 96-well micro-
titer plates. The bacterial numbers were calculated by measure-
ment of turbidity with a spectrophotometer (DU530; Beckman,
Fullerton, CA, U.S.A.). MICs were determined by a serial two-fold
dilution of test peptides, following the recommendations of the
Clinical and Laboratory Standards Institute (CLSI). After 24 h of
incubation at 37 °C, the minimal peptide concentration required to
prevent the growth of a given test organism was determined and
was deﬁned as the MIC. The growth was assayed with a microtiter
ELISA Reader (Molecular Devices Emax, CA, U.S.A.) by monitoring
absorption at 620 nm [22].
2.6. Hemolytic activity assay
The hemolytic activity of the peptides was evaluated by measuring
theabsorbance at414 nmwith anELISAReader todetermine the release
of hemoglobin from a 4% suspension of human erythrocytes [17].
The hemolysis percentage was calculated using the following equation:
%Hemolysis=100[(Abs414 nm in the peptide solution−Abs414 nm in
PBS)/(Abs414 nm in 0.1% Triton X-100−Abs414 nm in PBS)].
2.7. Membrane depolarization assay
Measurements of cytoplasmic membrane depolarization were
made using amembrane potential-sensitive probe, diSC35. DiSC35was
purchased from Sigma Chemical Co. (USA). E. coli O-157 cells were
grown at 37 °C to mid-log phase, centrifuged (3500 rpm, 7 min) and
washed with 5 mM HEPES buffer (pH 7.2) containing 20 mM glucose
and resuspended in buffer (5 mM HEPES buffer, 20 mM glucose,
100 mM KCl, pH 7.2) to an OD600 of 0.05. Changes in ﬂuorescence due
to the collapse of the cytoplasmic membrane potential were
continuously monitored at 20 °C using a Shimadzu RF-5301 spectro-
ﬂuorophotometer at an excitation wavelength of 622 nm and an
emission wavelength of 670 nm. When the dye uptake was maximal,
as indicated by a stable reduction in ﬂuorescence due to quenching of
the accumulated dye in the membrane interior, peptides (at the MIC)
were added to the cells. Measurements were repeated two times
under each condition to ensure reproducibility [23].
2.8. Preparation of FD-loaded liposome and leakage assay
FITC-labeled dextrans (FD4, FD10, and FD20) were employed to
evaluate the extent of membrane damage induced by the peptides. All
FDs were purchased from Sigma Chemical Co. (USA). To prepare FD-
entrapped liposome, buffer I (1 ml, 50 mM potassium phosphate, pH
7.4, with 0.1 mM EDTA) containing 2 mg/ml of FD, was sonicated for
30 min with 20 mg/ml of lipid [PE/PG (7:3, w/w)] solution in
chloroform on ice. Chloroformwas removed by using a rotary vacuum
evaporator for 2 h at 25 °C, resulting ﬁrst in the formation of a viscous
gel, and then a liposome suspension. Buffer I (2 ml) was added and the
suspension was evaporated further for the removal of eventual traces
of chloroform. The liposome suspension was sonicated, centrifuged
and washed for several cycles at 13,000 rpm for 30 min to remove
unentrapped-FD. For the assay, the peptides (at theMIC) were treated
in a suspension of FD-loaded liposome. The mixture (3 ml, ﬁnal
volume) was stirred for 10 min in the dark and then centrifuged at
13,000 rpm for 20 min. The supernatant was recovered and its
ﬂuorescence intensity was recorded by measuring a ﬂuorescent
intensity, at wavelengths (λex=494 nm, λem=520 nm), with RF-
5301PC spectroﬂuorophotometer (Shimadzu, Japan). 20 μl of 10%
Table 1
Physicochemical properties of Rev–NIS and its analogs.
Peptide Amino acid
sequence
Calculated
value
Observed
value
Net
charge
Retention
time
(min)
Hydrophobicity
Rev–
NIS
ELLKAVRLIK 1182.5 1183.2 +2 18.992 −0.161
Anal R RLRKAVRLIK 1252.6 1251.9 +5 13.550 −0.502
Anal S ELSKAVRLIK 1156.4 1155.8 +2 15.433 −0.24
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[24,25]. The percentage of dye leakage was calculated as follows: % FD
leakage=100×(F−F0)/(Ft−F0), where F represents the ﬂuorescent
intensity achieved by the peptides treatment (at the MIC) and F0 and
Ft represent the ﬂuorescent intensities without the peptides treat-
ment and with Triton X-100 treatment, respectively.
3. Results
3.1. Design and secondary structures of the analogs of Rev–NIS
As noted, we designed the analogs of Rev–NIS, Anal R, and Anal S,
based on the boundary of the hydrophobic and the charged/polar
regions of the peptide (Fig. 1). Speciﬁcally, Anal R was designed to
increase the net positive charge, considered the signiﬁcant factor
regarding the interaction between the peptide and the bacterial cell
plasma membranes, and Anal S was designed to decrease the
hydrophobicity, related to both the cytotoxicity and the hydrophobic
interaction with themembranes (Table 1). As a result, the net positive
charge of Anal R has increased from +2 to +5 and no change has
been made to Anal S. Regarding the hydrophobicity, we did
calculation by using Eisenberg–Weiss scale and came up with the
conclusion that Anal R had the value of−0.502 while Anal S had the
value of −0.24 and Rev–NIS had that of −0.161.
First, to investigate the alteration of the secondary structure of the
analogs, after the amino acid substitution, CD spectroscopy was
performed in membrane-like environments. Previously, Rev–NIS was
known to have an α-helical structure [16], and as shown in Fig. 2, the
results showed that the analogs, Anal R and Anal S, were characterized
by exhibiting double negative ellipticity in both 50% TFE and 30 mM
SDS. It meant that the two analogs maintained the Rev–NIS-like helix,
regardless of the substitution.
3.2. Antibacterial and hemolytic activities of Rev–NIS and its analogs
In this study, melittin was used as a positive control peptide for
comparing the potency of the peptides. Melittin is the main
component in the venom of the honey bee Apis mellifera and is one
of the typical membrane-disruptive AMPs, helping researchers to
investigate lipid–peptide interactions. It also possesses potent anti-
bacterial and hemolytic activities [26–28]. As shown in Table 2,
although melittin showed the most potent activities, Rev–NIS and its
analogs also showed remarkable antibacterial activities, with MIC
values in the 2.5–40 μM range, against 6 Gram-positive bacteria and 6
Gram-negative bacteria, including antibiotics-resistant bacterial
strains, such as MRSA or ARPA. Furthermore, the cytotoxicity assay
was conducted against human erythrocytes. The result showed that
Rev–NIS did not cause any hemolysis, such as the experiment
performed in the previous study [17], and that the analogs did notFig. 1. Helical wheel diagram of the analogs of Rev–NIS. The diagram is drawn at a
rotation angle of 108° per peptide bond [16]. The oblique line indicates the boundary
between the hydrophobic (left) residues and the charged/polar (right) residues.induce hemolytic effects at any of the tested concentrations that are
similar to that of Rev–NIS (Table 3). The results of the antibacterial
susceptibility testing and the hemolysis assay suggest that the
analogs, as well as Rev–NIS, can be developed as novel antibacterial
agents without remarkable cytotoxicity.
3.3. Rev–NIS and its analog-induced membrane leakage in intact
bacterial cells, using diSC35 assay
In the previous study, Rev–NIS has shown to exert its antifungal
activity via membrane-active mechanism [17]. Like Rev–NIS, many
AMPs are considered to have a common target site, the cytoplasmic
membrane, regarding their antimicrobial activity. Therefore, to
investigate the effects of Rev–NIS and its analogs on the bacterial
cytoplasmic membrane, the membrane-depolarization experiments
using the membrane-sensitive dye diSC35 was conducted against E.
coli O-157, as compared to melittin. The addition of all the peptides
resulted in an increase of diSC35 ﬂuorescence intensity, and this
increase demonstrated that the peptides induced membrane depo-
larization in E. coli O-157 (Fig. 3). Also, the pattern in the result of the
diSC35 assay mostly corresponded to the result of the antibacterial
susceptibility testing (Anal RNRev–NISNAnal S).
3.4. Size of the pores formed by Rev–NIS and its analogs in bacterial
model membranes, using FITC-dextran leakage
To elucidate the extent of membrane damage induced by Rev–NIS
and its analogs, the release of FD of manifold sizes (FD4, FD10, and FD
20) from liposome was assessed. The liposome consisted of PE/PG
(7:3, w/w) and this composition was derived from the inner
membrane of E. coli. The average molecular mass of FD4, FD10, and
FD20 is 3.38, 10.1, and 14.8 kDa, respectively. Also, the hydrodynamic
radius (Stokes radius) of FD4, FD10, and FD20 is known to be 1.4, 2.3,
and 3.3 nm, respectively [29]. As shown in Fig. 4, on average, Rev–NIS,
Anal R, and Anal S released 16.828%, 21.147%, and 2.568% of FD4 from
the liposome. Interestingly, Anal R further induced the release of
FD10, with 7.158%. However, all the peptides, except for melittin,
could not induce the leakage of FD20 from liposome. This result
indicated that Rev–NIS and Anal S made pores in the bacterial model
membranes, with the radius between 1.4 nm and 2.3 nm. The radius
of the pores made by Anal R is thought to exceed 2.3 nm, but below
3.3 nm.
4. Discussion
AMPs are one of the most signiﬁcant components of the natural
defenses of many living organisms against invading pathogenic
microorganisms. Although the sequence, length, or structure of AMPs
is not consistent, their molecular weight is relatively small (b10 kDa)
and speciﬁcally, they have two representative properties such as
cationicity and amphipathicity. With respect to the structure of AMPs,
the peptides are classiﬁed into ﬁve groups as followings: (a) α-helical
peptides, (b) cysteine-rich peptides, (c) β-sheet peptides, (d) histatin,
arginine, and proline-rich peptides, and (e) peptides composed of
uncommon or modiﬁed amino acids. These AMPs are known to exert
Fig. 2. CD spectra of the analogs of Rev–NIS. (A) Rev–NIS. (B) Anal R. (C) Anal S.
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ing bacteria, fungi, yeast, protozoa, viruses, and antibiotics-resistant
strains. Additionally, AMPs have been isolated from various vertebrates,
invertebrates, animals, plants, bacteria and fungi.Moreover, someAMPs
are derived frommacrophages, neutrophils, epithelial cells, hemocytes,
fat body, and the reproductive tract [30].
The Rev protein of HIV-1 is known as a post-transcriptional
transactivator for structural and enzymatic viral gene expression. Rev
protein also allows both unspliced and incompletely-spliced viral
mRNAs to be efﬁciently transported out of the nucleus of the host
cells, and translated on polysomes [31–34]. This series of processes
are carried out by the direct interaction between the Rev protein and
its structural RNA target, on such HIV-1 mRNAs, the speciﬁc region
entitled the Rev responsive element (RRE) [35–37]. Furthermore,
many studies regarding HIV-1 have suggested that Rev is shuttling
between the cytoplasm and the nucleus of the host cells [12–15],
mediated by the NLS (nuclear localization signal), the NOS (nucleolar
targeting signal) [38] and the NES (nuclear export signal) of Rev itself
[39–41]. As mentioned above, NIS region is also crucial for the cycle
survival of HIV-1.Table 2
Antibacterial activity of Rev–NIS and its analogs.
MIC (μM)
Rev–NIS Anal R Anal S Melittin
Gram-positive bacteria
E. faecium 10 5 10 2.5
MRSA 1 5 2.5 10 1.25
MRSA 2 10 5 20 2.5
MRSA 3 10 5 20 2.5
MRSA 4 10 5 10–20 5
MRSA 5 20 10–20 40 5
Gram-negative bacteria
ARPA 1 10 5 20 2.5
ARPA 2 5 2.5–5 10 1.25
ARPA 3 10 10 20 5
ARPA 4 10 5 20 5
ARPA 5 5 2.5 10–20 2.5
E. coli O-157 10 5 20 1.25
E. faecium: Enterococcus faecium, MRSA: methicillin-resistant Staphylococcus aureus,
ARPA: antibiotics-resistant Pseudomonas aeruginosa, E. coli O-157: Escherichia coli O-
157.We focused on the AMPs from the species that are not mentioned
above and found the Rev–NIS peptide derived from the HIV-1 Rev
protein. Rev–NIS is not only cationic but also amphipathic, and
according to our previous study, this peptide is known to contain an
anticandidal property. Actually, short peptides such as Rev–NIS have
been speciﬁcally considered as the model for therapeutic agents.
Regarding not only the production costs but also the susceptibility to
human proteolytic enzymes, short peptides are thought to possess
many advantages. Long peptides are very susceptible to enzymes in
the gastrointestinal track [42]. Contrarily, short peptides are less
susceptible to the enzymes and can be absorbed after oral adminis-
tration, without difﬁculty [43]. Those are the reasons that this short
peptide consisting of 10 amino acids, Rev–NIS, is considered as a
potential antibacterial peptide. Furthermore, in this study, we
designed two analogs, to investigate the effects of the substituted
amino acids, arginine and serine, on the activity of Rev–NIS.
Prior to the investigation of the antibacterial effects of the
peptides, we checked the variation of secondary structures of the
analogs. The CD spectroscopy results were interesting. Both Anal R
and Anal S displayed the same conformation of Rev–NIS, with a
signiﬁcant fraction of helical structure, and as mentioned above, the
amino acid-substitutions did not affect the peptide secondary
structure. The degree of peptide helicity is also different according
to the environments. Next, Rev–NIS and its analogs are active against
Gram-negative and Gram-positive bacteria, mainly the antibiotic
resistant strains such as MRSA and ARPA in this study; however, they
do not lyse eukaryotic cells such as human erythrocytes. Particularly,
Rev–NIS and its analogs possessed a signiﬁcant activity pattern, Anal
RNRev–NISNAnal S. However, there was no speciﬁc discrepancy
between Gram-positive and Gram-negative bacteria, regarding the
activity of the peptides. Signiﬁcantly, in the case of Anal R and Anal S,
the net positive charge was thought to be more crucial than the
hydrophobicity and the helicity, regarding the antibacterial activity. InTable 3
Hemolytic activity of Rev–NIS and its analogs.
Peptide %Hemolysis (μM)
100 50 25 12.5 6.25 3.13 1.56
Rev–NIS 0 0 0 0 0 0 0
Anal R 0 0 0 0 0 0 0
Anal S 0 0 0 0 0 0 0
Melittin 100 100 100 100 100 100 98
Fig. 3. Effects of melittin, Rev–NIS, and its analogs on the membrane potential of intact E. coli O-157 cells (OD600=0.05). DiSC35 ﬂuorescence was measured as described in Materials
and methods. The peptides were treated at the MIC value. (A) Cells treated with melittin. (B) Cells treated with Rev–NIS. (C) Cells treated with Anal R. (D) Cells treated with Anal S.
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the resistance of bacteria, and they can be one of the most promising
potential next generation antibiotic models.
The amphipathic property can induce the effective interactions of
the peptides with the cell plasma membranes, consisting of
phospholipids. Thus, a representative characteristic, observed for
membrane-active peptides, is their disruptive action toward bilayerFig. 4. Percentage of FITC-dextran (FD) leakage induced by melittin, Rev–NIS, and its
analogs from PE/PG [7:3 (w/w)] liposome. The peptides were treated at the MIC value.
The error bars represent the standard deviation values for three independent
experiments, performed in triplicate.integrity, like depolarization and pore formation. This action on the
membranes can often lead to the collapse of the transmembrane
electrochemical gradients and, consequently, provide a description
regarding the cell killing activities [44,45]. The pore formation affects
cellular respiration [46], deprives organisms of an energy source by
disrupting the electrochemical gradient, across free-energy transduc-
tion within the membranes [47,48]. Lastly, this process results in cell
swelling and osmolysis, due to the ﬂow of ion or water [27,49].
In the previous study, Rev–NIS showed the antifungal activity via
the membrane-disruptive action against C. albicans. To examine that
Rev–NIS also showed antibacterial effects by a similar mode of action,
we ﬁrst performed diSC35 assay using E. coli O-157. This dye is a
membrane potential-sensitive ﬂuorescent probe [50]. If it crosses the
outer membrane, diSC35 can be taken up by the cells, according to the
magnitude of the electrical potential gradient of the cytoplasmic
membrane, and thereafter, it accumulates in the membrane, where it
self-quenches its own ﬂuorescence. Providing that the peptides
disrupt the cytoplasmic membrane and that this action results in
the depolarization of the ΔΨ, the electrical potential gradient, we can
check the release of diSC35 through the increase of ﬂuorescence [51].
The result indicated that all the peptides remarkably disrupted the
cytoplasmicmembrane of E. coliO-157 and that the pattern of potency
was consistent with the result of MIC assay (Anal RNRev–NISNAnal
S). It further suggests that the substituted positively charged arginine
(R) is very signiﬁcant in the interaction between the peptide and the
negatively charged LPS, PE or PG of the E. coli O-157. Regarding PE, in
E. coli cells, the ﬂuorescence signal of Ro (Ro09-0198)-bound PE is
uniformly distributed in the cell surface, and this observation
indicates that PE is uniformly localized over the whole bacterial cell
membrane [52]. Ro is the cyclic peptide probe that can bind
speciﬁcally to PE [53]. Moreover, it was thought that the decreased
hydrophobicity, by substituting serine (S), weakened the hydropho-
bic interactions between the hydrophobic residues of Rev–NIS and the
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interactions of the positively charged amino acids, such as K4, R7,
and K10, with the negatively charged components. When considering
the pattern of hydrophobicity, this fact supported that the net positive
charge is one of the most crucial factors.
To conﬁrm themode of action of the peptides, the FD leakage assay
was conducted. This assay, using FDs of both the different molecular
weight and the radius, is a method to elucidate the pore-forming
mechanism in the membrane perturbation process [54,55]. The radius
of Rev–NIS and its analogs-induced pores may be anywhere from
1.4 nm to 2.3 nm. Also, the radius of pores induced by Anal R is
considered to be from 2.3 nm to 3.3 nm. This result indicated that the
substituting with two arginines increased the net positive charge of
the peptide, and thereafter, the increased positive charge makes the
interaction between the peptide and the negative charged compo-
nents more potent. It meant that the high afﬁnity regarding the
interaction between the positively charged residues of Anal R induced
larger pores than other peptides. In conclusion, these results suggest
that the peptides in this study make pores in the bacterial cell
membranes, can affect cellular respiration, and cause the membrane
to transport water or ions. Finally, the peptides can be thought to
cause the bacterial cell death. Considering that the negatively charged
phospholipids are uniformly distributed in both the outer and the
inner membranes of bacteria, as compared with those of fungi and
mammals, speciﬁcally, Anal R possessingmany arginines is thought to
be a potent candidate as a novel antibacterial agent.
Our ultimate goals have been to develop and suggest novel non-
toxic antibiotic peptides with noticeable potency and range of
susceptible microorganisms to be of practical utility. The pore forming
peptides studied herein, Rev–NIS and its analogs, Anal R, and Anal S,
were conducive with the conditions mentioned above, and among the
peptides, Anal R can be a novel potential antibiotic itself or a template
for designing new therapeutic agents.
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